The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+5.1% to $418.00
Predicted High$418.00at 6 months
Predicted Low$392.50at 1 month
Max Drawdown (predicted)-1.3%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 11, 2026 1:20 am
Bull
ELV trends higher to
$418.00
(+5.1% from $397.70)
by Feb 2027.
dip-then-recover
ThesisELV screens cheap on DCF and composite fair value but quality and sentiment are negative, and the stock has quietly gained 17% over 6 months on near-zero beta. With no earnings catalyst in the window and value gravity working slowly, expect a modest drift higher toward the signal-adjusted anchor, punctuated by a soft patch as the recent rally digests.
Invalidated ifA break below $360 on managed-care headline risk, or failure to reclaim $410 by November, would falsify the slow-grind-higher thesis.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $397.70 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 11, 2026
—
$397.70at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 25, 2026
$368.22–$427.18typical range · internal point $396.00
—
±7.4%
6/10
Low-beta drift, no catalyst, mild digestion of recent run
1 month
Sep 11, 2026
$354.98–$440.42typical range · internal point $392.50
—
±10.7%
5/10
Sentiment fade and quality headwind pull toward $390 support
2 months
Oct 11, 2026
$399.00
—
+0.3%
4/10
Stabilization ahead of Q3 print expectations building
Year-end positioning into defensive low-beta names
5 months
Jan 11, 2027
$415.00
—
+4.4%
4/10
Value gravity toward signal-adjusted $405 already cleared
6 months
Feb 11, 2027
$418.00
—
+5.1%
3/10
Slow convergence toward composite fair value continues
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$408.04
(+2.6%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.